Wird geladen...
Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient
Crizotinib is an oral small-molecule inhibitor of anaplastic lymphoma kinase (ALK) tyrosine-kinase that has been approved for treating patients with advanced echinoderm microtubule associated protein like 4-ALK rearranged non-small-cell lung cancer (NSCLC). Toxic epidermal necrolysis (TEN) is a rare...
Gespeichert in:
| Veröffentlicht in: | Mol Clin Oncol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795818/ https://ncbi.nlm.nih.gov/pubmed/29456853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1553 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|